Inovio Pharmaceuticals, Inc.
Vaccines For Recurrent Respiratory Papillomatosis And Methods Of Using The Same

Last updated:

Abstract:

Provided herein are nucleic acid molecules encoding an HPV antigen. Also provided are vaccines against human papillomavirus (HPV) comprising the nucleic acids, methods of inducing immune responses, and methods for prophylactically and/or therapeutically immunizing individuals against recurrent respiratory papillomatosis (RRP). Pharmaceutical compositions, recombinant vaccines comprising DNA plasmid and live attenuated vaccines are disclosed as well as methods of inducing an immune response to treat or prevent RRP are disclosed.

Status:
Application
Type:

Utility

Filling date:

14 May 2021

Issue date:

18 Nov 2021